Total Payments
$238,474
2024 Payments
$38,892
Companies
4
Transactions
263
Medicare Patients
1,176
Medicare Billing
$234,502
Payment Breakdown by Category
Other$191,858 (80.5%)
Travel$37,507 (15.7%)
Consulting$4,869 (2.0%)
Food & Beverage$4,241 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $191,858 | 56 | 80.5% |
| Travel and Lodging | $37,507 | 140 | 15.7% |
| Consulting Fee | $4,869 | 2 | 2.0% |
| Food and Beverage | $4,241 | 65 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $236,061 | 258 | $0 (2024) |
| Spark Therapeutics, Inc. | $2,175 | 1 | $0 (2021) |
| Boston Scientific Corporation | $217.56 | 3 | $0 (2023) |
| MERZ NORTH AMERICA, INC. | $20.38 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,892 | 35 | GENZYME CORPORATION ($38,892) |
| 2023 | $19,705 | 27 | GENZYME CORPORATION ($19,661) |
| 2022 | $14,230 | 18 | GENZYME CORPORATION ($14,056) |
| 2021 | $5,493 | 3 | GENZYME CORPORATION ($3,318) |
| 2020 | $1,816 | 3 | GENZYME CORPORATION ($1,796) |
| 2019 | $45,592 | 44 | GENZYME CORPORATION ($45,592) |
| 2018 | $59,296 | 59 | GENZYME CORPORATION ($59,296) |
| 2017 | $53,450 | 74 | GENZYME CORPORATION ($53,450) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological), LUMIZYME | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,417.00 | General |
| Category: Genetic Disease | ||||||
| 10/24/2024 | GENZYME CORPORATION | LUMIZYME (Biological), NEXVIAZYME | Travel and Lodging | In-kind items and services | $227.06 | General |
| Category: Genetic Disease | ||||||
| 10/24/2024 | GENZYME CORPORATION | LUMIZYME (Biological), NEXVIAZYME | Food and Beverage | In-kind items and services | $54.41 | General |
| Category: Genetic Disease | ||||||
| 10/24/2024 | GENZYME CORPORATION | LUMIZYME (Biological), NEXVIAZYME | Food and Beverage | Cash or cash equivalent | $37.00 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological), LUMIZYME | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,713.00 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological), LUMIZYME | Travel and Lodging | In-kind items and services | $1,122.55 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological), LUMIZYME | Travel and Lodging | In-kind items and services | $508.71 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological), LUMIZYME | Travel and Lodging | In-kind items and services | $279.41 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological), LUMIZYME | Food and Beverage | In-kind items and services | $125.36 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological), LUMIZYME | Travel and Lodging | Cash or cash equivalent | $58.00 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological), LUMIZYME | Food and Beverage | Cash or cash equivalent | $38.00 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological), LUMIZYME | Travel and Lodging | Cash or cash equivalent | $14.94 | General |
| Category: Genetic Disease | ||||||
| 09/14/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,417.00 | General |
| Category: Genetic Disease | ||||||
| 09/14/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological) | Travel and Lodging | In-kind items and services | $217.16 | General |
| Category: Genetic Disease | ||||||
| 09/14/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological) | Food and Beverage | In-kind items and services | $123.12 | General |
| Category: Genetic Disease | ||||||
| 09/14/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological) | Food and Beverage | In-kind items and services | $109.03 | General |
| Category: Genetic Disease | ||||||
| 09/14/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $81.58 | General |
| Category: Genetic Disease | ||||||
| 09/14/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological) | Food and Beverage | Cash or cash equivalent | $35.00 | General |
| Category: Genetic Disease | ||||||
| 09/13/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,713.00 | General |
| Category: Genetic Disease | ||||||
| 09/13/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological) | Travel and Lodging | In-kind items and services | $770.70 | General |
| Category: Genetic Disease | ||||||
| 09/13/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological) | Travel and Lodging | In-kind items and services | $489.18 | General |
| Category: Genetic Disease | ||||||
| 09/13/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological) | Travel and Lodging | In-kind items and services | $226.87 | General |
| Category: Genetic Disease | ||||||
| 09/13/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $73.84 | General |
| Category: Genetic Disease | ||||||
| 06/09/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological), LUMIZYME | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,491.00 | General |
| Category: Genetic Disease | ||||||
| 06/09/2024 | GENZYME CORPORATION | NEXVIAZYME (Biological), LUMIZYME | Travel and Lodging | In-kind items and services | $721.99 | General |
| Category: Genetic Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 309 | 570 | $262,107 | $54,280 |
| 2022 | 7 | 287 | 589 | $281,254 | $52,985 |
| 2021 | 7 | 299 | 660 | $313,660 | $61,228 |
| 2020 | 5 | 281 | 700 | $332,914 | $66,010 |
Total Patients
1,176
Total Services
2,519
Medicare Billing
$234,502
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 91 | 282 | $128,028 | $28,766 | 22.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 61 | 120 | $38,973 | $7,966 | 20.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 54 | 57 | $34,029 | $6,349 | 18.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 38 | $33,516 | $5,651 | 16.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 46 | 47 | $22,231 | $4,649 | 20.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 20 | 26 | $5,330 | $898.66 | 16.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 91 | 378 | $171,612 | $32,371 | 18.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 65 | 66 | $39,402 | $7,285 | 18.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 36 | $31,752 | $5,982 | 18.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 40 | 40 | $18,920 | $3,595 | 19.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 31 | 44 | $9,020 | $1,729 | 19.2% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 13 | 13 | $6,240 | $1,194 | 19.1% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2022 | 12 | 12 | $4,308 | $828.86 | 19.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 108 | 461 | $209,294 | $40,971 | 19.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 51 | 51 | $44,982 | $8,667 | 19.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 47 | 47 | $22,231 | $4,267 | 19.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 35 | 35 | $20,895 | $4,111 | 19.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2021 | 36 | 44 | $9,020 | $1,783 | 19.8% |
| 95909 | Nerve transmission studies, 5-6 studies | Facility | 2021 | 11 | 11 | $3,949 | $776.71 | 19.7% |
| 95908 | Nerve transmission studies, 3-4 studies | Facility | 2021 | 11 | 11 | $3,289 | $651.75 | 19.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 102 | 494 | $224,276 | $44,549 | 19.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 65 | 66 | $58,212 | $11,645 | 20.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 61 | 61 | $28,853 | $5,485 | 19.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 28 | 49 | $15,423 | $3,097 | 20.1% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2020 | 25 | 30 | $6,150 | $1,234 | 20.1% |
About Dr. Jay Han, M.D
Dr. Jay Han, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Orange, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1134100209.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Han, M.D has received a total of $238,474 in payments from pharmaceutical and medical device companies, with $38,892 received in 2024. These payments were reported across 263 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($191,858).
As a Medicare-enrolled provider, Han has provided services to 1,176 Medicare beneficiaries, totaling 2,519 services with total Medicare billing of $234,502. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Neuromuscular Medicine
- Location Orange, CA
- Active Since 11/07/2005
- Last Updated 04/24/2025
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1134100209
Products in Payments
- LUMIZYME (Drug) $158,338
- NEXVIAZYME (Biological) $45,618
- LUMIZYME (Biological) $2,860
- General - Therapies (Device) $173.71
- XEOMIN (Biological) $20.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Orange
Dr. David Majors, Md, MD
Physical Medicine & Rehabilitation — Payments: $18,719
Physical Medicine & Rehabilitation $18,719
Dr. Matthew Johnson, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $4,321
Physical Medicine & Rehabilitation $4,321
Michael Danto, Md, MD
Physical Medicine & Rehabilitation — Payments: $2,914
Physical Medicine & Rehabilitation $2,914
Dr. Fady Boutros, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $766.82
Physical Medicine & Rehabilitation $766.82
Marc Eivind Evensen, Md, MD
Physical Medicine & Rehabilitation — Payments: $428.77
Physical Medicine & Rehabilitation $428.77
Dr. Tony Nguyen, Md, MD
Physical Medicine & Rehabilitation — Payments: $324.53
Physical Medicine & Rehabilitation $324.53